Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance
Molecular Oncology · 2026-11 · 20 (11) · 2569-2583
DOI: 10.1002/1878-0261.70259 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 17.04.2026. Verfasst von Kanishka Tiwary und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York,…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Immunologic Surveillance, Neoplasm Metastasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health /National Cancer Institute, Mark Foundation For Cancer Research.
Abstract (Originalsprache)
Metastasis remains the leading cause of cancer‐related mortality. Even after major advances in early detection and systemic therapies, long‐term disease recurrence frequently arises from the presence of dormant disseminated tumor cells (DTCs) at distant sites. Dormant DTCs disseminate from the primary tumor and reside in secondary organs in a reversible quiescent state characterized by minimal proliferation, enabling resistance to therapies that target actively dividing cells. Despite their inactivity, dormant DTCs are far from inert. Dormant DTCs dynamically interact with the surrounding tumor microenvironment (TME), including stromal, vascular, and immune components, to establish niches that maintain quiescence while limiting immune detection. While the mechanisms by which proliferating cancer cells evade immune surveillance have been extensively studied, the processes governing immune regulation, immune‐mediated dormancy, and immune evasion of dormant DTCs remain incompletely integrated across literature. In this review, we explore recent advances describing how microenvironmental cues and immune pressures converge on tumor cell–intrinsic programs to sustain dormancy, promote immune tolerance, and enable long‐term survival of DTCs across different organs and cancer types. We further discuss conditions that disrupt this equilibrium and drive escape from dormancy, as well as emerging therapeutic strategies aimed at eliminating or controlling dormant DTCs by targeting dormancy‐specific immune and microenvironmental interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Kanishka Tiwary, Jose Javier Bravo-Cordero
Förderung
- NCI NIH HHS
- National Institutes of Health /National Cancer Institute
- Mark Foundation For Cancer Research
- Department of Defense, Breast Cancer Research Program
- Irma T. Hirschl Trust
Zitieren
APA
Tiwary, K., & Bravo-Cordero, J. J. (2026). Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance. Molecular Oncology, 20(11), 2569-2583. https://doi.org/10.1002/1878-0261.70259
Vancouver
Tiwary K, Bravo-Cordero JJ. Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance. Molecular Oncology. 2026;20(11):2569-2583. doi:10.1002/1878-0261.70259
BibTeX
@article{Tiwary2026,
author = {Tiwary, Kanishka and Bravo-Cordero, Jose Javier},
title = {Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {11},
pages = {2569--2583},
doi = {10.1002/1878-0261.70259}
}
EUVIMED